Loading stock data…
GDRX
$2.55+0.19 (+8.05%)
Market ClosedLast close May 1
GoodRx Holdings, Inc., together with its subsidiaries, offers information and tools that enable consumers to compare prices and save on their prescription drug purchases in the United States.
Historical Price
Price (Candle)
50-Day SMA
200-Day SMA
Whystock Brain
The Narrative
GoodRx Holdings, Inc. in the Healthcare sector is trading at $2.55. The stock is currently near its 52-week low of $1.77, remaining 19.0% below its 200-day moving average. Technical signals show overbought RSI of 71 and bullish MACD crossover, explaining why GDRX maintains its current current market pressure. The Whystock Score of 10/100 signals elevated caution as indicators diverge.
Ecosystem Influences
Overbought levels (RSI 71) — risk of consolidation or pullback
Long-term trend bearish (Price vs 200-day SMA)
Macro-economic sensitivity to interest rate and inflation shifts
Loading Financials...
Peer Comparison
JNJUNHPFE
Whystock Valuation Model
Whystock fair value is estimated using a trailing P/E model adjusted for return on equity: Fair P/E = 18 + (ROE × 20). Fair Value = (Current Price ÷ Trailing P/E) × Fair P/E. A base P/E of 18 represents a typical market multiple, scaled upward for companies that earn high returns on equity. The result is a theoretical "normalised" price — not a price target or investment advice. Large deviations are common for high-growth or loss-making companies.
Current Price$2.55
Potential Downside
27.4%
Whystock Fair Value$1.85
Price
UndervaluedFair ValueOvervalued
Simplified model based on P/E and ROE. Not a substitute for full valuation analysis. Data may be delayed. See our Terms.
Analyst Consensus13 analysts
Hold
Mean target$2.82+10.4%
Range$1.90 – $3.50
Fundamentals
GoodRx Holdings, Inc., together with its subsidiaries, offers information and tools that enable consumers to compare prices and save on their prescription drug purchases in the United States. The company operates a price comparison platform that prov...
Market Cap
Total dollar market value of a company's outstanding shares of stock (Price * Shares).
$811.90M
P/E Ratio
Priced for growth. Investors expect sustained double-digit expansion.
26.33
Beta
High-beta play. Expect amplified moves vs. the broad market.
1.47
Div Yield
Low to zero yield. Return is entirely dependent on price appreciation.
0.00%
ROE
Average efficiency. Growth may require heavy reinvestment.
5.61%
Volume
Today's trading volume
3.23M
Recent News
Sandisk and Whirlpool have been highlighted as Zacks Bull and Bear of the Day
Sandisk shines as AI-driven storage demand fuels growth, while Whirlpool struggles with weak earnings, margin pressure and a persistent stock downtrend.
OptimizeRx vs. GoodRx: Which Digital Health Stock is the Better Buy?
OPRX edges past GDRX with AI-driven platform momentum, stronger estimates and lower valuation despite near-term revenue headwinds.
Healthcare Technology Stocks Q4 Recap: Benchmarking GoodRx (NASDAQ:GDRX)
The end of the earnings season is always a good time to take a step back and see who shined (and who not so much). Let’s take a look at how healthcare technology stocks fared in Q4, starting with GoodRx (NASDAQ:GDRX).
1 Cash-Producing Stock with Exciting Potential and 2 We Ignore
Generating cash is essential for any business, but not all cash-rich companies are great investments. Some produce plenty of cash but fail to allocate it effectively, leading to missed opportunities.
3 Reasons GDRX is Risky and 1 Stock to Buy Instead
GoodRx’s stock price has taken a beating over the past six months, shedding 40.7% of its value and falling to $2.31 per share. This was partly due to its softer quarterly results and may have investors wondering how to approach the situation.